Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CALCOCO2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GPNMB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP6V1B2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBMS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNASEH2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASF1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RMDN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TLDC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BORCS8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC48A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYO1C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VWA5A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP1R18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HOXA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC9A9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LITAF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DERA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on